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Utility of endogenous creatinine clearance as a measure of renal
function in mice.
Background. The use of endogenous plasma creatinine lev-
els and creatinine clearance as a tool to evaluate renal function
in mice has come under scrutiny as prior studies have reported
that the Jaffe´ alkaline picrate method grossly overestimates true
plasma creatinine in mice. As members of the NIDDK Ani-
mal Models of Diabetic Complications Consortium (AMDCC),
we evaluated the performance and feasibility of an alterna-
tive high-performance liquid chromatography (HPLC)-based
method for standard determination of plasma creatinine and
creatinine clearance in mice. Our purpose was to develop a sim-
ple method that provides a reliable, reproducible, and sensitive
assay for small volumes (<25 lL) of mouse plasma and sera.
Methods. We compared creatinine clearance measured by
HPLC with the Jaffe´ method and HPLC creatinine clearance
with inulin clearance [fluoroscein isothiocyanate (FITC) inulin
in an osmotic pump implanted in mouse] in C57BL/6J mice.
Different groups of mice underwent either one of two protocols.
Protocol A included dietary intervention with normal, low salt
plus enalapril, or high salt. Protocol B induced diabetes using
streptozotocin.
Results. First, mean plasma creatinine levels were signifi-
cantly lower (P < 0.0001) by HPLC (0.128 ± 0.026 mg/dL) vs.
Jaffe´ (0.4 ± 0.12 mg/dL) for mice on a normal diet. Urine creati-
nine concentrations measured by HPLC were 10% lower than
by Jaffe´ (P < 0.01). Second, mean creatinine clearance by HPLC
for mice on a normal diet was 255 ± 68 lL/min. Mice on low
salt diet plus enalapril had reduced creatinine clearance (72.8 ±
24.2 lL/min) while mice on high salt diet had an elevated creati-
nine clearance (355 ± 105 lL/min). Third, diabetic mice (19 to 24
weeks of diabetes) exhibited hyperfiltration as creatinine clear-
ance was 524 ± 214 lL/min whereas nondiabetic age/gender-
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matched mice showed a mean creatinine clearance of 206 ±
41 lL/min. Finally, significant correlation was demonstrated for
creatinine clearance by HPLC vs. inulin clearance (R = 0.643;
P < 0.001).
Conclusion. HPLC is highly accurate, much more sensitive
and specific than the Jaffe´ method for plasma creatinine mea-
surements in mice. Creatinine clearance in mice measured by
HPLC reflects changes in renal function induced by diet and
diabetes.
The use of the mouse as an experimental model has
provided investigators with a portal to define and follow
the progression of renal disease by functional analysis,
histologic parameters, and molecular profiling. However,
a serious issue plaguing researchers has been the lack of
a simple, reproducible method to estimate renal func-
tion in conscious mice. Markers of glomerular filtration
rate (GFR) such as 51Cr-ethylenediaminetetraacetic acid
(EDTA), 14C-inulin, or 125I-iothalamate [1–5] have been
used; however. these methods required investigators to
inject the labeled marker (either fluorescent or radioac-
tive) into the mouse and subsequently measure the la-
beled compound in plasma and/or urine over a timed
interval. Difficulties have included problems obtaining
sufficient blood volume and accurately timed urine col-
lections over short periods. The measurement of an en-
dogenous compound, such as creatinine, to accurately
estimate the GFR would be a much simpler and more de-
sirable method. However, this would be dependent upon
the ability to accurately measure creatinine in plasma fil-
trates and urine from mice.
The assay for creatinine in plasma and urine of man
and animals dates back to 1905 when Folin [6] measured
a red color in the urine of individuals at 485 to 530 nm
using a chemical reaction defined by Jaffe´ in 1886 [7]. Al-
though the difficulties with the reaction with respect to
its lack of specificity and sensitivity have been discussed
[8, 9], most researchers have accepted the Jaffe´ reaction
or modifications of it as adequate for quantifying creati-
nine in plasma and urine of humans and in many large
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animals. Therefore, measurements based on the plasma
creatinine remain the most widely used method to assess
renal function in humans and large animals [10–18].
While the literature is replete with studies characteriz-
ing creatinine assays in human plasma and urine, equiva-
lent attention to the analogous assay in mouse plasma is
lacking. The use of plasma or serum creatinine measure-
ment as a tool to evaluate renal function in mice has been
called into question since Meyer et al [19, 20] reported
that creatinine levels in the blood (plasma) of mice mea-
sured by the Jaffe´ alkaline picrate method yielded sig-
nificantly higher levels (three to five times) than those
measured by high-performance liquid chromatography
(HPLC). These studies concluded that the Jaffe´ method
greatly overestimated the plasma creatinine levels, at-
tributing this increase to interferences by noncreatinine
chromagens. Despite the inaccuracy of serum/plasma cre-
atinine measured by the Jaffe´ reaction, this technique re-
mains widely used by the biomedical research community
to assess renal function [21–27] partly due to low cost and
ease of use.
Recently, Johns et al [28], using a strong cation ex-
change column, clearly showed marked advantages of
HPLC analysis for creatinine versus other colorimetric
and enzymatic methods in the plasma and urine of the
monkey, enabling accurate assessment of renal function
in the primate. In the present study, we describe a sim-
plified isocratic HPLC method based on Johns’ approach
that reliably measures very low levels of creatinine in
mouse plasma, sera, and urine and compares the plasma
and urine levels to those measured by the classical Jaffe´
alkaline picrate reaction. We also report creatinine clear-
ance by HPLC and compare it with GFR measurements
by inulin clearance in normal mice on varying diets and
in diabetic C57BL/6J mice.
METHODS
Animals and materials
C57BL/6J mice were purchased from Jackson Lab-
oratories (Bar Harbor, ME, USA). Fluorescein isoth-
iocyanate (FITC)-inulin, creatinine, enalapril, and
streptozotocin were obtained from Sigma Aldrich (St.
Louis, MO, USA). All reagents were HPLC grade unless
noted.
Mouse protocols
Experimental groups. All mouse protocols were
approved by Thomas Jefferson University’s and/or Van-
derbilt University’s Animal Use Committees prior to ini-
tiating the study. Part 1 of the study compared plasma
and urine creatinine levels along with 24-hour urine cre-
atinine excretion from 18 mice by two analytical methods
(HPLC and the Jaffe´ reaction). Part 2 compared plasma
creatinine (by HPLC), creatinine clearance, and inulin
clearance in three groups of C57BL/6J normal, female
mice receiving either normal (control) diet, a low salt diet
(0.03%) (Test Diet, Richmond, IN, USA) plus enalapril
(0.1 g/L in drinking water), or a high salt diet (3.15%). The
diets were given over 5 to 7 days, with urine and blood
collected on days 5 or 7. Part 3 compared plasma creati-
nine, creatinine clearance, and inulin clearance in normal
male C57BL/6J mice with their diabetic (streptozotocin-
induced) counterparts.
Streptozotocin induced diabetes mellitus model. At
8 weeks of age C57BL/6J male mice received daily in-
traperitoneal streptozotocin injections (50 mg/kg, freshly
made in 0.1 mol/L citrate buffer, pH 4.5) for 5 consec-
utive days. Blood glucose level of was examined weekly
with Accu-chek glucose meter (Roche Diagnostics, In-
dianapolis, IN, USA). Mice were considered diabetic if
their blood glucose level exceeded 300 mg/dL.
Urine and blood collections. Urine was collected over
24 hours using a Nalgene (Rochester, NY, USA) diuresis
cage (model 650-0323). Wire mesh and bottom of col-
lection vessel were pretreated with light coating of sil-
icone to decrease adhesion of small urine droplets to
plastic/metal, aiding in complete collection. Blood was
sampled through the retro-orbital sinus at the end of
the urine collection, under light isoflourane anesthesia
[29]. Approximately 300 lL of blood was collected with
a heparinized capillary tube (Fisher Scientific 02-668-66)
and collected in a Microtainer plasma separator (cata-
logue number 36-5958) tube containing lithium heparin
(Becton Dickinson, Franklin Lakes, NJ, USA). On aver-
age, this yielded 150 lL of plasma following centrifuga-
tion (3200 rpm for 10 minutes). Identical aliquots of blood
from 12 separate C57BL/6J mice were processed to yield
sera (no additives) or plasma containing either lithium
heparin or EDTA. The resulting plasma and sera were
assayed in an identical fashion by HPLC for creatinine
to test if any difference between sera or plasma could be
detected.
Measurement of creatinine in plasma and urine by
HPLC. Plasma collected from mice that was stored
in freezer (−20◦C) was thawed. Any fibrin clots were
squeezed and plasma centrifuged at 5000 rpm for 6 min-
utes. Twenty-five microliters of plasma were delivered
into a small (0.5 mL) Eppendorf tube. One hundred mi-
croliters of cold acetonitrile (ACN) that had been acid-
ified with 1:200 (vol/vol) of glacial acetic acid:ACN was
added to precipitate plasma proteins (1:4 ratio ACN to
plasma) [30]. The tube was vortexed and kept at 4◦C
for 15 minutes then centrifuged at 10,000 rpm for 10
minutes in a refrigerated centrifuge. The supernatant
was transferred to a new clean, labeled 0.5 mL Sarstedt
tube (Newton, NC, USA). The ACN and any aqueous
was evaporated to dryness in a Speed–Vac (Farmingdale,
NY, USA). The residue containing the creatinine was re-
suspended in 25 lL of HPLC mobile phase and trans-
ferred to an autosampler vial. The vial was capped and
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centrifuged in a swinging bucket rotor at 3000 rpm for
5 minutes to ensure any undissolved material remained
at bottom of vial. The vials were loaded into the autosam-
pler module of the HPLC system. The HPLC system
employed was a Perkin-Elmer Auto System (Shelton,
CT, USA) consisting of a Series 200 Binary Pump,
Autosampler, UV-Vis detector, vacuum degasser, and
Totalchrom, 6.2.1 software running on a Dell worksta-
tion under Windows 2000. HPLC columns (ZorbaxTM)
were purchased from Agilent Technologies (Wilming-
ton, DE, USA). Guard columns (JavelinTM), filters
and polyetherether ketone (PEEK) tubing were pur-
chased from ThermoHypersil-Keystone (Waltham, MA,
USA). Low dead volume polypropylene autosampler
vials and slit caps were purchased from National Scientific
(Duluth, GA, USA). All reagents were HPLC grade or
better and purchased through Fisher Scientific (Pitts-
burgh, PA, USA) unless otherwise noted. The mobile
phase that consisted of 2.00 L of 5 mmol/L sodium ac-
etate and adjusted to pH 4.2 ± 0.1 with HPLC grade
glacial acetic acid (1.4 mL). The solution was filtered
through a 0.22 lm nylon filter (catalogue number164-
0020) (Nalgene-Nunc, Rochester, NY, USA). Eighty
milliliters of methanol and 20 mL of ACN were added to
make a total volume of 2.10 L. Separation was achieved
on a 50 mm × 2.1 mm, 5 l particle size strong cation ex-
change column, Zorbax SCX, (Agilent, Wilmington DE,
USA) (catalogue number 860-700-704). Column oven
temperature was 45◦C; flow rate was set at 0.300 mL/min.
A 2 mm Javelin in-line filter (part number 88200) and
a Biobasic SCX, 10 × 2.1 mm guard column were used
precolumn. Back pressure ranged from 900 to 1050 psi.
Run time was 10 minutes. Detection of eluting creati-
nine peak was achieved at 225 nm at 3.65 ± 0.02 min-
utes. The concentration of creatinine was determined
from an external standard regression line (8 points) using
weighted 1x2 regression formula (Totalchrom
) (Perkin
Elmer Corp.). Plasma and urine creatinine levels for
comparison were also measured by the standard picric
acid-based colorimetric kinetic assay using a commercial
laboratory which utilized the Hitachi 717 Autoanalyzer
(Hitachi Life Sciences, San Jose, CA, USA).
Use of FITC-inulin for GFR estimation
A FITC-inulin osmotic minipump protocol was per-
formed as described by Qi and Breyer et al (manuscript
in press). Enough FITC-inulin to give a 4% solution was
dissolved in 0.45% NaCl by heating the solution in boiling
water. To remove residual unbound FITC, the solution
was dialyzed against pure water for 48 hours at 4◦C with
two water changes using a 1000 D cut-off dialysis mem-
brane (Spectra/Pro 6; Spectrum Laboratories, Inc., Ran-
cho Dominguez, CA, USA). The resulting 25% increase
in volume following dialysis yielded a final 3% FITC
solution that was then passed through a 0.22 lm filter
(Millipore, Bedford, MA, USA). Micro-osmotic pumps,
Alzet model 1007D with release rate of 0.5 lL/hour for 7
days (Durect Corp., Cupertino CA, USA), were filled
with the FITC-inulin wiped with BetadineTM and iso-
propyl alcohol pads, according to instructions in the pack-
age. The pumps were then placed at room temperature
in sterile saline 2 hours prior to implanting.
Implantation of micro-osmotic pumps. Mice were con-
tinuously anesthetized with isoflourane (Baxter Pharma-
ceutical Products Inc., Deerfield, IL, USA). Two micro-
osmotic pumps filled with 3% FITC-inulin were inserted
into peritoneal cavity through a small midline incision
(approximate 0.5 cm). The incision was closed in two
layers (peritoneum/muscle and skin) using interrupted
sutures with sterile 4–0 silk. After complete recovery
from anesthesia (about 5 minutes), mice were housed in
a group cage for 2 days. On day 4, they were individually
placed in diuresis cages and allowed free access to sweet-
ened water (2.5% glucose in sterile tap water) and food.
Urine was collected over 24 hours.
Measurement of FITC-inulin in plasma and urine.
Both plasma and urine samples were buffered to pH 7.4
with 500 mmol/L HEPES (pH 7.4). Previous data showed
HEPES buffer could maintain pH at 7.4 in 1:4 vol/vol ra-
tio buffer:specimen. (Zhonghua Qi, unpublished data).
Forty microliters of each urine or plasma were then
loaded onto a black-masked Costar (Corning, NY, USA)
96-well plate (catalog number 3603). Ten microliters of
the HEPES buffer was added and mixed sample/well.
Fluorescence was determined using a Cytofluor 2300
plate reader (Millipore), with filters of 485 ± 20 nm for
excitation, and read at 530 ± 25 nm for emission. The
concentration of FITC inulin was determined by mea-
suring fluorescence intensity and comparing to known
concentrations of standards derived from serial dilutions
of a stock FITC-inulin solution ranging from 0.0 lg/mL
(HEPES/saline blank) to 100 lg/mL. Standards and spec-
imens were treated in the same fashion (i.e., 40 lL stan-
dard or specimen and 10 lL HEPES.
Statistics
All data are expressed as the arithmetic mean ± 1 SD.
Graphs show arithmetic means ± SEM. Either a paired
or independent t test was used for single variable test-
ing. Where comparisons were between more than two
variables, single-factor analysis of variance (ANOVA)
was used with Newman-Keuls post hoc testing. In cases
where the data showed unequal variances, either a t test
with the Welch correction or a non-parametric statistic
was applied (Mann-Whitney or Wilcoxon tests). Corre-
lations are expressed as Pearson’s correlation coefficient.
A value for P less than 0.05 for a two-sided test was con-
sidered significant. SYSTAT (version 5.2), Instat (ver-
sion 1.14), and Prism (version 2.0) statistical software
were used for computations.
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Fig. 1. Deproteinized mouse plasma, 3 lL injection. (A) Peak at 1.2 minutes is unknown. Creatinine appears as a singlet at 3.6 minutes. This peak
represents a plasma creatinine value of 0.116 mg/dL. (B) Deproteinized, diluted mouse urine. Peak at 3.6 minutes corresponds to creatinine. Earlier
peaks are unknown.
RESULTS
HPLC assay of creatinine in mouse plasma
Figure 1 shows chromatograms of typical mouse
plasma and urine sample. The retention time for crea-
tinine is 3.65 minutes. Clear baseline separation is noted
which enables low concentration to be measured at high
instrument sensitivities. For an eight-point calibration
curve, a plot of detector response (area units) versus con-
centration (mg/dL) yielded a correlation coefficient of
0.9998 using the Totalchrom software provided with the
HPLC instrument. A linear relationship was noted over
three orders of magnitude (r = 0.9995) using Excel (Mi-
crosoft, Redmond, WA, USA) or Prism (San Diego, CA,
USA) software providing an alternative for those without
the aid of the Totalchrom software. The limit of reliable
detection (signal/noise ratio >10) for a 3.0 lL injection
was 0.0078 mg/dL. The method showed reproducibility
at the lowest end to be 12.1%. In the range between 0.03
mg/dL and 0.125 mg/dL, reproducibility was 5.1%. From
0.126 through 1.00, reproducibility was 3.5%. Day-to-day
standards in the 0.125 through 1.00 range, using a 3.00 lL
injection and an autosampler, yielded less than 3% vari-
ation from the mean. Recovery of added creatinine from
pooled mouse plasma was 96% (89% to 102%). Urine
specimens were diluted 1:5 or greater with deionized wa-
ter and processed in same fashion as plasma. Protein pre-
cipitation efficiency was 95.6%.
Comparison of HPLC and Jaffe´ measurements of
creatinine in mouse plasma, sera, and urine
Comparison of heparinized plasma, EDTA-derived
plasma and sera showed that sera gave a 5.7% ± 2.2%
higher value than plasma, but this level did not reach
statistical significance (P = 0.622) by repeated measures
ANOVA. No difference was detected between either
lithium or EDTA plasma. Plasma (lithium heparin) was
used in all following assays. Plasma creatinine levels were
measured in identical aliquots by HPLC and Jaffe´ reac-
tion in a group of 18 normal C57BL/6J mice. As noted in
Figure 2A, the range of plasma creatinine levels in nor-
mal mice fell within a tight region (0.05 to 0.15 mg/dL)
as measured by HPLC. With a Jaffe´-based reaction, the
spread in normal mice was much wider (0.2 to 0.5 mg/dL).
A clear overestimation of plasma creatinine by Jaffe´
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Fig. 2. Comparison of creatinine levels. (A) Levels measured by Jaffe´ (Picric acid) method (•) and by high-performance liquid chromatography
(HPLC) (◦) in mouse plasma. Significantly higher creatinine levels in plasma (P < 0.0001) by Jaffe´ measurement are shown. (B) Same data plotted
to show ratios. Jaffe´ overestimates creatinine in plasma, with values by Jaffe´ falling above the line of equivalence (dashed line). (C) Same data as
a regression to demonstrate that a correlation between Jaffe´ and HPLC measurements (R = 0.738; P < 0.01) exists, but lack of sensitivity of Jaffe´
method is apparent.
compared to HPLC was evident (P < 0.0001). Due to
the reduced sensitivity of the Jaffe´ method, concentra-
tions below 0.2 mg/dL were not measurable, and values
could only be expressed to one significant figure. A direct
plot of the ratio of the two plasma creatinine measure-
ments showed all values above the line of equivalency
(dashed line) further demonstrating that Jaffe´ markedly
overestimates plasma creatinine (Fig. 2B). Nevertheless,
a significant overall correlation between Jaffe´ and HPLC
(R = 0.738, R2 = 0.545, P < 0.01) (Fig. 2C) existed al-
though wide variability and lack of sensitivity was appar-
ent with the Jaffe´ method.
Urine creatinine concentrations were similar in nor-
mal mice as measured by either HPLC or Jaffe´ (Fig. 3A),
although a 10% difference was found between the two
methods with respect to urine concentrations (P < 0.01).
The line of equivalence showed the concentrations found
by HPLC to be lower than by Jaffe´ (Fig. 3B). A high de-
gree of correlation between urine creatinine measured
by HPLC and Jaffe´ was found (R = 0.985, R2 = 0.970,
P < 0.0001) (Fig. 3C). The creatinine clearance in
mice was underestimated by Jaffe´ compared to HPLC
(Fig. 3D) due to the higher plasma creatinine level mea-
sured by Jaffe´.
Table 1 depicts the range of values of creatinine found
in normal male and female C57BL/6J mice. The plasma
creatinine concentration measured by HPLC in normal
mice ranged from 0.097 to 0.184 mg/dL with a mean of
0.128 ± 0.026 mg/dL. This mean value was threefold less
than that found by Jaffe´ (range 0.2 to 0.5). Urine concen-
trations are also presented for comparison. The 24-hour
creatinine excretion measured by HPLC ranged from 242
to 598 lg with a mean of 418 ± 100 lg. The wide range
for 24-hour urine creatinine excretion was likely due to
difficulties in obtaining complete urine collections from
mice via metabolic cages.
Use of HPLC-based creatinine measurements to
estimate renal function in mice with altered renal function
To study whether HPLC-based plasma creatinine mea-
surements could distinguish mice with altered renal
function, different groups of mice underwent dietary
modification or were made diabetic with streptozotocin.
In the diet modification study, three groups of female
C57Bl/6J mice were given either a normal diet, a high
salt diet, or a low salt diet with enalapril added. The
plasma creatinine measurements by HPLC showed over-
all differences between the three groups (P < 0.001)
(Fig. 4A). With normal diet, the mean plasma creatinine
was 0.133 ± 0.027 mg/dL. In the high salt group, mean
plasma creatinine was 0.080 ± 0.016 mg/dL, and in the
low salt plus enalapril group, mean plasma creatinine was
0.362 ± 0.129 mg/dL. Creatinine clearances showed some
overlap between the normal (255 ± 68 lL/min/mouse)
and the high salt group (355 ± 105 lL/min/mouse). How-
ever, the low salt plus enalapril group exhibited clearly
lower values of creatinine clearance without overlap
(72.8 ± 24 lL/min/mouse, P < 0.001 versus both the nor-
mal and the high salt groups) (Fig. 4B). Normalizing the
creatinine clearances for body weight showed a similar
pattern (Fig. 4C).
Male C57BL/6J mice were made diabetic with a mul-
tiple low dose streptozotocin regimen at 7 to 9 weeks of
age. After 19 to 24 weeks of diabetes, the mean blood
glucose in the diabetic mice was 435 ± 132 mg/dL com-
pared to 133 ± 32 mg/dL in the nondiabetic mice. Mean
body weights were similar in both groups at baseline, al-
though the diabetic mice were slightly lower at the end
of the study (25.9 ± 2.4 versus 29.4 ± 2.3, P = 0.012).
The diabetic mice had significantly lower plasma crea-
tinine values (P < 0.001) than nondiabetic mice (0.064
± 0.042 versus 0.125 ± 0.019 mg/dL) and higher crea-
tinine clearances (524 ± 214 versus 206 ± 41 lL/min;
1964 Dunn et al: Plasma creatinine in mice
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Fig. 3. Comparison of creatinine levels. (A)
Levels measured by Jaffe´ (Picric acid) method
() and by high-performance liquid chro-
matography (HPLC) () in mouse urine. A
small but statistically significant difference is
noted between HPLC and Jaffe´ creatinine
measurements in urine (P = 0.01). The fig-
ure illustrates similarity between HPLC and
Jaffe´ creatinine measurements. (B) Dashed
line shows same data plotted with the line
of equivalency. All values fall on or slightly
above the line of equivalency consistent with
a 10% overestimation by Jaffe´. (C) Strong
correlation between both methods for urine
creatinine (R = 0.985, P < 0.0001). (D) Jaffe´
method underestimates creatinine clearance
in mice. Ratios fall well below the line of
equivalency.
Table 1. Mean plasma creatinine level measured in 18 C57BL/6J mice by high-performance liquid chromatography (HPLC)
Plasma creatinine Plasma creatinine Urinary creatinine Urinary creatinine
Gender Age weeks Body weight g HPLC mg/dL Jaffe´ mg/dL HPLC mg/dL Jaffe´ mg/dL
C57BL/6J (N = 10) F 8–30 20.0 ± 1.0 0.131 ± 0.031 0.4 ± 0.10 1.92 ± 0.0 2.3 ± 0.9
C57BL/6J (N = 8) M 29–34 29.4 ± 2.3 0.125 ± 0.019 0.4 ± 0.10 7.27 ± 1.77 7.8 ± 2.0
All mice (N = 18) F (10) M (8) 22 ± 7.7 24.2 ± 5.1 0.128 ±.026a 0.4 ± 0.12a 4.30 ± 3.02b 4.7 ± 3.1b
Mean plasma creatinine level measured in eighteen C57BL/6J mice by HPLC is significantly different (P < 0.0001) from same plasma measured by Jaffe´ colorimetric
analysis using the alkaline picric acid reaction. A small (10%) difference between urine concentrations (HPLC vs. Jaffe´ colorimetric method) was detected (P = 0.01).
aP < 0.0001; bP = 0.01
P < 0.001) (Fig. 5A and B). Creatinine clearance normal-
ized for body weight showed a similar pattern (Fig. 5C).
Renal function was assessed simultaneously by HPLC-
based creatinine assay and a FITC-inulin based method
in conscious mice. The study included mice given various
salt intakes as well as the diabetic mice described above.
A significant correlation between creatinine clearance by
HPLC with FITC-inulin clearance (R = 0.643, P < 0.001)
was found (Fig. 6).
DISCUSSION
The goal of the present investigation was to determine
if measurement of endogenous plasma or serum creati-
nine and/or creatinine clearance could be used to track
changes in renal function with a simple noninvasive mea-
surement in conscious mice. Using the HPLC-based cre-
atinine measurement, we determined that it is feasible
to reliably measure renal function in mice in the nor-
mal range and to distinguish between normal and altered
renal function in mice using plasma creatinine or cre-
atinine clearance. Thus, streptozotocin-induced diabetic
C57BL/6J mice clearly exhibit hyperfiltration after 4 to 6
months of diabetes. Similarly, intake of a high salt diet in-
creased creatinine clearance compared to mice on a nor-
mal salt intake. Such measurements are below the level of
sensitivity of colorimetric reactions as the true creatinine
values are below 0.2 mg/dL in normal mice. Additionally,
HPLC-based creatinine clearance is able to reflect mod-
erately impaired renal function as seen in mice given a
Dunn et al: Plasma creatinine in mice 1965
0.0
0.1
0.2
0.3
0.4
0.5
0.6
Pl
as
m
a 
cr
ea
tin
in
e,
 m
g/
dL
No
rm
Hig
h s
alt
Lo
w s
alt
+ 
en
ala
pri
l
Plasma creatinine
No
rm
Hig
h s
alt
Lo
w s
alt
+ 
en
ala
pri
l
Creatinine clearance
NS
P < 0.01
P < 0.01
A
P < 0.01
P < 0.01
P < 0.05
B
0
50
100
150
200
250
300
350
400
450
500
Cr
ea
tin
in
e 
cle
ar
an
ce
,
µ L
/m
in
/m
ou
se
No
rm
Hig
h s
alt
Lo
w s
alt
+ 
en
ala
pri
l
Creatinine creatinine
normalized for body weight
P < 0.01
P < 0.01
P < 0.05C
Cr
ea
tin
in
e 
cle
ar
an
ce
,
µ L
/m
in
/g
 B
W
0
5
10
15
20
25
30
Fig. 4. Plasma creatinine measurements. (A) High-performance liquid chromatography (HPLC) for C57BL/6J mice receiving a normal diet, high
salt, and low salt diet + enalapril. (B) Corresponding creatinine clearance (HPLC). (C) The normalized creatinine clearances per gram of body
weight.
0.00
0.05
0.10
0.15
0.20
0.25
0.30
m
g/
dL
Plasma creatinine Creatinine clearance
P < 0.001
A
P < 0.001
B
0
100
200
300
400
500
600
700
800
900
1000
µL
/m
in
/m
ou
se
Creatinine clearance
normalized for body weight
P < 0.001
C
µL
/m
in
/g
 B
W
0
5
10
15
20
25
30
35
40
45
50
Normal Diabetic Normal Diabetic Normal Diabetic
Fig. 5. Plasma creatinine measurements. (A) High-performance liquid chromatography (HPLC) for C57BL/6J age/sex-matched normal mice
(N = 8) and diabetic mice (N = 12). (B) Corresponding creatinine clearances (HPLC). (C) The normalized creatinine clearances per gram of body
weight.
low salt diet with enalapril. Whether creatinine secretion
plays an important role in mice remains unclear based on
our results. Subsequent studies will be required to deter-
mine if the degree of creatinine secretion changes in mice
with different levels of renal function.
Using HPLC to measure creatinine in mouse plasma,
our data confirmed that the Jaffe´ reaction did, in fact,
overestimate true creatinine levels in the mouse plasma
by threefold, similar to prior reports by Meyer et al [19,
20]. Due to the lack of reliability of creatinine measure-
ments in mouse plasma or sera by Jaffe-based methods,
changes in renal function would be more accurately mea-
sured by HPLC. With advanced renal failure, it remains
possible that Jaffe´ based creatinine measurement may be
sufficient to reflect changes in renal function, although
the absolute values would be inaccurate [31].
With respect to urine creatinine, we found that the
measurement of creatinine in mouse urine by Jaffe´ over-
estimated the HPLC creatinine by about 10%. There-
fore, for most applications, such as using urine crea-
tinine to normalize spot urine concentration of other
metabolites (i.e., mg of compound × per mg of creati-
nine), the Jaffe´ based urine creatinine may be acceptable.
For more accurate physiology studies, HPLC for measur-
ing creatinine in both plasma/sera and urine would be
preferable.
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Fig. 6. Inulin clearance correlates with creatinine clearance when
plasma is measured by high-performance liquid chromatography
(HPLC).
Substances interfering with the Jaffe´ reaction capable
of reacting with picric acid include known compounds like
hemoglobin, lipids, acetone, albumin, bilirubin, glucose,
acetoacetate, pyruvate, nitrophenols, and others [32]. Di-
rect measurement of creatinine, as in the case with HPLC,
versus forming a colored derivative, as the Jaffe´ reaction
requires, eliminates a significant number of possible in-
terfering substances that would also combine with picric
acid to form picrates and give false positive. The method
we developed has additional distinct advantages. First,
currently, we use 25 lL of plasma, which gives us the
best reproducibility (intra-assay precision of 3.1%), but
smaller volumes as low as 5 lL are quite possible. Second,
using a narrow bore column permits faster analysis times
and less band spreading allowing the sensitivity of the
method to surpasses any current optical detection meth-
ods enabling us to see as little as 0.23 ng of creatinine
passing through the 12 lL flow cell. This translates into
confident measurements to three significant figures, a fac-
tor not available with Jaffe´ reactions. Third, maintaining
the pH of the mobile phase at 4.2 is (about 0.8 pH units
above the pKa of creatinine which is between 4.8 [33]
and 5.0 [28] yields a consistently better signal/noise ratio
and lower ultraviolet absorptivity of the mobile phase.
Fourth, detection of creatinine at 225 nm under the pH
conditions noted above gave a 10% increase in signal
versus 234 nm [28] or 205 nm [17] yielding higher sen-
sitivity with no increase in background. Finally, protein
precipitation using acetic acid and acetonitrile gave over
96% protein removal, eliminated any artifact from HCl,
and allowed the method to be ported to mass spectrom-
etry by using a volatile acid that can be removed easily.
The volatility of the acetic acid does require fresh mobile
phase to be made bi-weekly. The method is fast, reliable,
and scalable. Under the conditions reported, no interfer-
ing substances eluted along with creatinine peak mak-
ing the method quite robust and reproducible for mouse
plasma. Columns are stable over time and between runs
making this method a good candidate for validation under
the “Guidance for Industry-Bioanalytical Method Vali-
dation” procedures [34].
The estimated GFR by the FITC-inulin method was
lower than the creatinine clearance by HPLC. Based on
prior reports, the average GFR of conscious mice using
a single-shot technique was in the range of 400 lL/min
[2], which is similar to the HPLC creatinine clearance we
found. We suspect that the FITC inulin clearance may
be lower due to loss of FITC during the urine collection.
Although the true GFR in conscious mice still remains
unclear, our data demonstrate that both HPLC-based
creatinine clearance and the FITC-inulin methods to es-
timate GFR in conscious mice yield similar results and
are significantly correlated.
CONCLUSION
We have developed a simple, highly specific and sen-
sitive isocratic HPLC method to accurately measure cre-
atinine in plasma, sera, and urine in mice. This method
allows for measurement of renal function in conscious
mice using an endogenous marker of renal function.
Based on the present data and prior reports [19, 20], the
AMMDCC has adopted the HPLC method as the pre-
ferred method to measure plasma creatinine in mice, as
an index of endogenous renal function.
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